+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Dihydromyrcene & Derivatives Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 186 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6120751
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Dihydromyrcene & Derivatives Market grew from USD 65.17 million in 2025 to USD 71.24 million in 2026. It is expected to continue growing at a CAGR of 5.49%, reaching USD 94.74 million by 2032.

Dihydromyrcene and derivatives are becoming indispensable aroma workhorses as performance, transparency, and reliability redefine value

Dihydromyrcene and its derivatives sit at the intersection of two forces reshaping modern consumer products: the premiumization of fragrance experiences and the industrial need for reliable, scalable aroma ingredients. As a hydrogenated derivative within the terpene family, dihydromyrcene is valued for its clean, fresh, citrus-leaning profile and its utility as a building block in broader fragrance accords. It is commonly positioned as an enabling ingredient, strengthening performance across diverse product formats where stability, cost control, and consistent sensory output matter.

In today’s fragrance value chain, buyers are no longer focused solely on odor character. They are scrutinizing the total performance envelope, including oxidation resistance, compatibility with surfactants and solvents, and the ability to hold up under heat and light in distribution. At the same time, regulatory and brand-led expectations around ingredient transparency and responsible sourcing continue to rise, pushing manufacturers to improve documentation and quality control practices across upstream feedstocks and downstream blending.

Against this backdrop, the dihydromyrcene & derivatives landscape is best understood as a pragmatic, application-driven market where formulation needs, compliance requirements, and supply reliability determine competitive advantage. This executive summary outlines the most meaningful shifts influencing demand patterns, trade and tariff pressures, segmentation-driven opportunities, regional dynamics, and the company behaviors most likely to differentiate winners from followers.

Documentation rigor, resilient sourcing, and performance-led formulation are reshaping how dihydromyrcene portfolios compete and win

The competitive landscape is being transformed by how fragrance houses and ingredient producers respond to tighter requirements on safety documentation, allergen considerations, and product stewardship. Even when dihydromyrcene itself is not at the center of regulatory debates, customers increasingly require more granular evidence of compliance, including consistent specifications, impurity profiles, and change-control commitments. As a result, suppliers are investing in stronger QA systems and harmonized documentation that can travel across multiple jurisdictions without creating delays in customer qualification.

In parallel, the industry is shifting from a single-objective pursuit of cost optimization toward multi-objective optimization that balances cost, sensory performance, and supply resilience. Recent disruptions across petrochemical and natural feedstock chains have encouraged buyers to qualify dual sources, negotiate more detailed supply agreements, and favor producers that can demonstrate robust business continuity planning. This has reinforced the role of intermediates and derivatives portfolios as hedging tools, allowing formulators to adjust blends when particular inputs become constrained.

Sustainability expectations are also reshaping how dihydromyrcene and derivatives are positioned. Customers increasingly ask whether inputs are derived from renewable terpene streams, whether manufacturing routes are energy-efficient, and how emissions are managed across production. While adoption of third-party sustainability credentials varies by end-use, the direction of travel is clear: suppliers that can offer credible, auditable narratives about sourcing and manufacturing practices gain a commercial advantage in tenders and long-term supply discussions.

Finally, innovation in encapsulation, controlled release, and performance boosters for home and personal care is elevating the importance of ingredient stability and functional behavior. This pushes dihydromyrcene derivatives from being simple odor contributors toward roles as performance enablers in complex systems such as concentrated detergents, scent boosters, and long-lasting fine fragrance formats. Consequently, the competitive arena is increasingly defined by technical service, application testing, and co-development rather than by commodity-style sales alone.

U.S. tariffs in 2025 add compounding friction to landed costs, supplier qualification, and formulation choices across aroma inputs

The cumulative impact of United States tariffs in 2025 is likely to be felt less as a single shock and more as a compounding set of cost, timing, and compliance frictions across the aroma-chemical supply chain. For dihydromyrcene and related derivatives, tariff exposure depends on country of origin, the specific classification under U.S. customs codes, and whether products enter as neat materials, blends, or incorporated components. This creates a practical reality in which two functionally similar inputs may land at materially different delivered costs based purely on routing and documentation.

As tariffs layer on top of freight variability, insurance costs, and port processing constraints, procurement teams are expected to intensify their focus on landed-cost modeling. This will reward suppliers capable of providing stable delivery windows, accurate export paperwork, and transparent origin declarations that reduce the risk of customs holds. In addition, tighter scrutiny can elevate the importance of consistent batch-to-batch specifications, because re-testing or rework delays effectively amplify the cost impact of tariffs through downtime and expedited logistics.

Tariffs may also accelerate strategic shifts in supplier qualification. U.S.-based buyers that previously relied on a narrow set of overseas producers may broaden their approved vendor lists, including regional or nearshore options that offer lower trade friction even if base pricing is higher. Over time, this can reshape negotiation power and contract structures, with customers pushing for tariff-sharing mechanisms, indexed pricing, or flexible delivery terms that protect them from sudden policy changes.

Importantly, the 2025 tariff environment can influence innovation pathways. When tariff pressure makes certain inputs less economical, formulators may re-balance toward alternate derivatives, adjust accord structures, or redesign finished goods to maintain margin without sacrificing perceived quality. Suppliers that provide formulation support-such as substitution guidance, stability testing, or olfactive equivalency work-can turn tariff-driven disruption into a customer-retention advantage, positioning themselves as solution partners rather than interchangeable sources.

Segmentation reveals demand is dictated by application stress, end-use compliance, and channel-led service expectations more than scent alone

Segmentation performance in dihydromyrcene & derivatives is best interpreted through the lens of use-case specificity, because buying criteria vary sharply by how the ingredient is deployed. Across product type, dihydromyrcene competes with a range of terpene-derived and hydrocarbon-based aroma ingredients, and the strongest demand tends to follow those variants that deliver consistent freshness, controllable diffusion, and good stability in water-based systems. Derivatives that extend longevity or improve compatibility in challenging matrices often gain preference when brands push for longer-lasting scent experiences.

When viewed by application, the market behaves differently in fine fragrances versus functional fragrances. In fine fragrance, the ingredient’s value is linked to olfactive elegance, the ability to brighten top notes, and its role in complex accords without overpowering signature characters. In functional fragrance, including home and personal care, the emphasis shifts toward performance under stress-high pH detergents, bleach adjacency, heat cycles in laundry, and long shelf lives in retail. This makes technical validation and application testing decisive, especially as brands launch more concentrated or “performance” labeled formats.

End-use segmentation further clarifies where decision-makers concentrate their scrutiny. In personal care, safety assessments and compatibility with surfactants, preservatives, and packaging are central, and buyers frequently prioritize suppliers with strong documentation and consistent organoleptic profiles. In home care, cost-in-use and stability often dominate, with demand shaped by the continued push toward scent boosters, multi-sensory cleaning experiences, and longer-lasting freshness on fabrics and surfaces. In air care, volatility management and controlled release take precedence, favoring derivatives and blends that can maintain character over time in gels, aerosols, and plug-in systems.

Looking at distribution channel segmentation, direct sales relationships tend to matter most when customers require technical collaboration, audit support, and reliable change management. Distributors remain important for smaller buyers, regional coverage, and just-in-time availability, but they face rising expectations to provide regulatory support and traceability documentation comparable to producers. Finally, segmentation by grade and specification underscores a widening gap between customers who can accept broader ranges and those who require tight limits on impurities, color, and odor nuances; this gap is increasingly monetized through service levels, documentation depth, and the ability to guarantee consistency at scale.

Regional demand is shaped by regulation intensity, manufacturing scale, and logistics reliability, making service consistency a global differentiator

Regional dynamics in dihydromyrcene & derivatives reflect differences in manufacturing ecosystems, regulatory posture, and the maturity of downstream fragrance demand. In the Americas, decision-making is strongly shaped by large home and personal care brands that require dependable supply and rigorous documentation, especially as trade policy uncertainty raises the value of diversified sourcing. Buyers in this region often emphasize operational reliability, lead-time consistency, and the ability to support reformulations quickly when compliance or cost pressures emerge.

In Europe, the market is influenced by a high bar for product stewardship and a sophisticated fine fragrance and consumer goods base that values both performance and transparency. Regulatory expectations and brand commitments can accelerate demand for suppliers that can demonstrate robust quality systems, detailed safety dossiers, and proactive change-control processes. As a result, technical service depth and the ability to navigate compliance requirements across multiple countries become critical differentiators.

The Middle East and Africa present a blend of opportunities driven by growing consumer goods manufacturing and strong fragrance cultural preferences in certain markets. Demand can be shaped by the expansion of local blending and filling operations, with buyers seeking reliable inputs that can be adapted to diverse product formats. Logistics reliability and distributor capabilities often determine how effectively suppliers can serve this region, particularly where import procedures or infrastructure variability affects delivery timelines.

In Asia-Pacific, scale, speed, and diversification of demand define the landscape. The region includes major manufacturing hubs for consumer products and a broad base of fragrance consumption across income tiers, which supports both high-volume functional fragrance demand and fast-evolving preferences in personal care. Competitive intensity can be higher, with customers expecting rapid sampling, flexible supply options, and strong technical responsiveness. At the same time, differing national regulatory regimes and documentation standards reinforce the need for suppliers to manage compliance proactively and tailor support to each market’s requirements.

Across all regions, the common thread is that customers increasingly reward suppliers that can provide not only consistent material but also consistent answers-on origin, specification integrity, and regulatory readiness-without slowing down product development cycles.

Winning companies differentiate through integrated sourcing, derivatives breadth, and technical service that converts aroma chemistry into customer outcomes

Company strategies in the dihydromyrcene & derivatives space increasingly converge on three competitive levers: portfolio breadth, operational excellence, and customer-facing technical capability. Producers with integrated access to terpene feedstocks or reliable upstream partnerships are better positioned to manage variability in input availability and maintain stable specifications. This matters because customers often treat aroma ingredients as mission-critical to product identity; unexpected variability can trigger requalification costs and commercial risk.

Another clear differentiator is the ability to offer a coherent derivatives family rather than a single molecule. Customers benefit when a supplier can provide adjacent options that maintain a similar freshness signature while adjusting diffusion, tenacity, or matrix compatibility. This portfolio approach supports substitution during supply disruptions and enables co-development, where the supplier helps customers optimize performance for specific bases such as detergents, body washes, or air care substrates.

Leading companies also invest in regulatory readiness and stewardship infrastructure. Strong documentation packages, rapid response to customer questionnaires, and disciplined change management increasingly determine supplier status in large-scale procurement. In practice, the “company insight” that matters most is not merely who can manufacture, but who can consistently support qualification processes across multiple markets while maintaining service levels.

Finally, commercial success is closely tied to application labs and technical service teams that speak the language of formulators. The most effective players translate ingredient attributes into measurable outcomes such as stability, odor longevity, and sensory impact under real-world conditions. As competition intensifies, companies that institutionalize customer collaboration-through pilots, troubleshooting, and tailored recommendations-are more likely to secure long-term relationships than those that rely on transactional selling.

Leaders can outpace rivals by hardwiring resilience, tariff-aware sourcing, application validation, and documentation as revenue enablers

Industry leaders should prioritize resilience planning that treats dihydromyrcene and derivatives as strategically important inputs rather than interchangeable commodities. This begins with stronger multi-sourcing strategies supported by clear equivalency protocols, so that alternates can be activated without destabilizing fragrance performance. In parallel, procurement and R&D teams should align on shared specifications and acceptable variability bands, reducing the risk that commercial urgency forces technically risky substitutions.

Next, leaders should institutionalize landed-cost governance that accounts for tariffs, routing, documentation, and delay risk. Cross-functional reviews that include supply chain, regulatory, and formulation stakeholders can surface hidden cost drivers such as re-testing, customs holds, or accelerated shipping. Contract structures should be updated to clarify responsibilities for tariff exposure and to build in mechanisms for transparent adjustments when policy conditions change.

On the growth side, companies should intensify application-led innovation. Investing in performance testing for key bases-high-pH laundry, concentrated cleaners, and long-lasting personal care formats-helps translate ingredient choices into defensible product claims. Where derivatives can offer measurable improvements in longevity or stability, leaders should package these benefits into customer-ready technical narratives that shorten sales cycles and increase conversion in competitive tenders.

Finally, leaders should treat documentation and stewardship as revenue enablers. Building standardized regulatory dossiers, allergen statements where applicable, and traceability narratives reduces friction during qualification and supports customers facing their own transparency commitments. Over time, this approach strengthens customer retention, because switching suppliers becomes not just a pricing exercise but a governance and risk decision.

A triangulated methodology combines expert interviews, regulatory and trade analysis, and application mapping to ground decisions in reality

The research methodology integrates primary and secondary inputs to build a decision-oriented view of the dihydromyrcene & derivatives ecosystem. Secondary research focuses on publicly available regulatory frameworks, trade and customs considerations, corporate disclosures, patent and innovation signals, and technical literature relevant to terpene chemistry and fragrance performance. This stage establishes the structural context for how products are manufactured, qualified, transported, and incorporated into downstream applications.

Primary research emphasizes expert validation and practical workflow insights from industry participants across the value chain, including producers, distributors, formulators, and procurement stakeholders. Interviews are designed to clarify real purchasing criteria, qualification bottlenecks, substitution behaviors, and the operational impact of policy changes such as tariffs. Qualitative insights are triangulated across multiple perspectives to reduce single-source bias and to ensure the findings reflect how decisions are made in practice.

Analytical synthesis is then applied to connect segmentation logic with regional and company behaviors. This includes mapping use-case requirements to material attributes, comparing compliance expectations across jurisdictions, and identifying patterns in how customers evaluate risk and performance. Throughout, the approach prioritizes consistency checks-cross-referencing claims against documentation norms and observable industry practices-so that conclusions remain grounded in verifiable realities rather than speculative assumptions.

The market’s direction is clear: performance validation, resilient supply, and stewardship excellence will define long-term advantage

Dihydromyrcene and its derivatives are increasingly valued as reliable, performance-forward ingredients that help fragrance systems meet modern expectations for stability, longevity, and consistent sensory delivery. As downstream brands seek differentiation through scent experiences while simultaneously tightening requirements for transparency and compliance, the competitive bar for suppliers continues to rise.

The landscape is being shaped by three reinforcing dynamics: stronger documentation and stewardship expectations, the need for resilient and tariff-aware sourcing, and an innovation cycle that rewards ingredients with demonstrable performance in demanding product bases. These dynamics elevate the strategic importance of technical service and derivatives portfolios that allow customers to optimize formulations without compromising identity or reliability.

Ultimately, decision-makers who treat dihydromyrcene & derivatives as part of a broader risk-and-performance strategy-rather than a single-line procurement item-will be best positioned to protect continuity, accelerate development, and strengthen customer relationships in an increasingly scrutinized fragrance ecosystem.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Dihydromyrcene & Derivatives Market, by Product Type
8.1. Dihydro Myrcenol
8.2. Dihydromyrcene
8.3. Tetrahydromyrcene
9. Dihydromyrcene & Derivatives Market, by Purity Grade
9.1. Food Grade
9.2. Industrial Grade
9.3. Pharmaceutical Grade
10. Dihydromyrcene & Derivatives Market, by Form
10.1. Gel
10.2. Liquid
10.3. Powder
11. Dihydromyrcene & Derivatives Market, by Manufacturing Process
11.1. Biocatalysis
11.2. Catalytic Hydrogenation
12. Dihydromyrcene & Derivatives Market, by Application
12.1. Flavor
12.1.1. Beverage Flavor
12.1.2. Food Flavor
12.2. Fragrance
12.2.1. Fine Fragrance
12.2.2. Functional Fragrance
12.3. Personal Care
12.3.1. Hair Care
12.3.2. Skin Care
12.4. Pharmaceutical
12.4.1. Active Ingredient
12.4.2. Drug Intermediate
13. Dihydromyrcene & Derivatives Market, by End Use
13.1. Cosmetics
13.1.1. Color Cosmetics
13.1.2. Hair Care
13.1.3. Skin Care
13.2. Food And Beverage
13.3. Household Products
13.4. Pharmaceuticals
14. Dihydromyrcene & Derivatives Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Dihydromyrcene & Derivatives Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Dihydromyrcene & Derivatives Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Dihydromyrcene & Derivatives Market
18. China Dihydromyrcene & Derivatives Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Aamirav Ingredients and Specialties Pvt. Ltd.
19.6. Anthea Group
19.7. BASF SE
19.8. Chemvera Specialty Chemicals Pvt. Ltd.
19.9. Firmenich International SA
19.10. Givaudan AG
19.11. Hebei Chuanghai Biotechnology Co., Ltd.
19.12. Herbochem Industries Private Limited
19.13. Himalaya Terpenes Pvt. Ltd.
19.14. International Flavors & Fragrances Inc.
19.15. Jiangxi Yono Industry Co., Ltd.
19.16. Mane SA
19.17. PCIPL
19.18. Privi Speciality Chemicals Limited
19.19. Robertet SA
19.20. Sivaroma Naturals
19.21. Symrise AG
19.22. T. Hasegawa Co., Ltd.
19.23. Takasago International Corporation
List of Figures
FIGURE 1. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PURITY GRADE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY MANUFACTURING PROCESS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY DIHYDRO MYRCENOL, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY DIHYDRO MYRCENOL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY DIHYDRO MYRCENOL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY DIHYDROMYRCENE, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY DIHYDROMYRCENE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY DIHYDROMYRCENE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY TETRAHYDROMYRCENE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY TETRAHYDROMYRCENE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY TETRAHYDROMYRCENE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FOOD GRADE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FOOD GRADE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FOOD GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY INDUSTRIAL GRADE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY INDUSTRIAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY INDUSTRIAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL GRADE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY GEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY GEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY GEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY BIOCATALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY BIOCATALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY BIOCATALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY CATALYTIC HYDROGENATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY CATALYTIC HYDROGENATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY CATALYTIC HYDROGENATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FLAVOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FLAVOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FLAVOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY BEVERAGE FLAVOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY BEVERAGE FLAVOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY BEVERAGE FLAVOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FOOD FLAVOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FOOD FLAVOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FOOD FLAVOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FRAGRANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FRAGRANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FRAGRANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FRAGRANCE, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FINE FRAGRANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FINE FRAGRANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FINE FRAGRANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FUNCTIONAL FRAGRANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FUNCTIONAL FRAGRANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FUNCTIONAL FRAGRANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PERSONAL CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PERSONAL CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PERSONAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY HAIR CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY HAIR CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY HAIR CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY SKIN CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY SKIN CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY SKIN CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY ACTIVE INGREDIENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY ACTIVE INGREDIENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY ACTIVE INGREDIENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY DRUG INTERMEDIATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY DRUG INTERMEDIATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY DRUG INTERMEDIATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COSMETICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COSMETICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COSMETICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COLOR COSMETICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COLOR COSMETICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COLOR COSMETICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY HAIR CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY HAIR CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY HAIR CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY SKIN CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY SKIN CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY SKIN CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FOOD AND BEVERAGE, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FOOD AND BEVERAGE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FOOD AND BEVERAGE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY HOUSEHOLD PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY HOUSEHOLD PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY HOUSEHOLD PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FRAGRANCE, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FRAGRANCE, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FRAGRANCE, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 139. LATIN AMERICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FRAGRANCE, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
TABLE 152. EUROPE DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. EUROPE DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 154. EUROPE DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 155. EUROPE DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 156. EUROPE DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
TABLE 157. EUROPE DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 158. EUROPE DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 159. EUROPE DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FRAGRANCE, 2018-2032 (USD MILLION)
TABLE 160. EUROPE DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
TABLE 161. EUROPE DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
TABLE 162. EUROPE DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 163. EUROPE DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FRAGRANCE, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
TABLE 173. MIDDLE EAST DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
TABLE 174. MIDDLE EAST DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 175. MIDDLE EAST DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
TABLE 176. AFRICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. AFRICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 178. AFRICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 179. AFRICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 180. AFRICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
TABLE 181. AFRICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 182. AFRICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 183. AFRICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FRAGRANCE, 2018-2032 (USD MILLION)
TABLE 184. AFRICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
TABLE 185. AFRICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
TABLE 186. AFRICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 187. AFRICA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FRAGRANCE, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
TABLE 197. ASIA-PACIFIC DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
TABLE 198. ASIA-PACIFIC DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 199. ASIA-PACIFIC DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 201. ASEAN DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. ASEAN DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 203. ASEAN DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 204. ASEAN DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 205. ASEAN DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
TABLE 206. ASEAN DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 207. ASEAN DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 208. ASEAN DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FRAGRANCE, 2018-2032 (USD MILLION)
TABLE 209. ASEAN DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
TABLE 210. ASEAN DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
TABLE 211. ASEAN DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 212. ASEAN DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
TABLE 213. GCC DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 214. GCC DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 215. GCC DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 216. GCC DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 217. GCC DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
TABLE 218. GCC DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 219. GCC DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 220. GCC DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FRAGRANCE, 2018-2032 (USD MILLION)
TABLE 221. GCC DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
TABLE 222. GCC DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
TABLE 223. GCC DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 224. GCC DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FRAGRANCE, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
TABLE 237. BRICS DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 238. BRICS DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 239. BRICS DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 240. BRICS DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 241. BRICS DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
TABLE 242. BRICS DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 243. BRICS DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 244. BRICS DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FRAGRANCE, 2018-2032 (USD MILLION)
TABLE 245. BRICS DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
TABLE 246. BRICS DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
TABLE 247. BRICS DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 248. BRICS DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
TABLE 249. G7 DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 250. G7 DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 251. G7 DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 252. G7 DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 253. G7 DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
TABLE 254. G7 DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 255. G7 DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 256. G7 DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FRAGRANCE, 2018-2032 (USD MILLION)
TABLE 257. G7 DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
TABLE 258. G7 DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
TABLE 259. G7 DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 260. G7 DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
TABLE 261. NATO DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 262. NATO DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 263. NATO DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 264. NATO DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 265. NATO DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
TABLE 266. NATO DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 267. NATO DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 268. NATO DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FRAGRANCE, 2018-2032 (USD MILLION)
TABLE 269. NATO DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
TABLE 270. NATO DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
TABLE 271. NATO DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 272. NATO DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
TABLE 273. GLOBAL DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 274. UNITED STATES DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 275. UNITED STATES DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 276. UNITED STATES DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 277. UNITED STATES DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 278. UNITED STATES DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
TABLE 279. UNITED STATES DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 280. UNITED STATES DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 281. UNITED STATES DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FRAGRANCE, 2018-2032 (USD MILLION)
TABLE 282. UNITED STATES DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
TABLE 283. UNITED STATES DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
TABLE 284. UNITED STATES DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 285. UNITED STATES DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
TABLE 286. CHINA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 287. CHINA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 288. CHINA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
TABLE 289. CHINA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 290. CHINA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
TABLE 291. CHINA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 292. CHINA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
TABLE 293. CHINA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY FRAGRANCE, 2018-2032 (USD MILLION)
TABLE 294. CHINA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PERSONAL CARE, 2018-2032 (USD MILLION)
TABLE 295. CHINA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
TABLE 296. CHINA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
TABLE 297. CHINA DIHYDROMYRCENE & DERIVATIVES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Dihydromyrcene & Derivatives market report include:
  • Aamirav Ingredients and Specialties Pvt. Ltd.
  • Anthea Group
  • BASF SE
  • Chemvera Specialty Chemicals Pvt. Ltd.
  • Firmenich International SA
  • Givaudan AG
  • Hebei Chuanghai Biotechnology Co., Ltd.
  • Herbochem Industries Private Limited
  • Himalaya Terpenes Pvt. Ltd.
  • International Flavors & Fragrances Inc.
  • Jiangxi Yono Industry Co., Ltd.
  • Mane SA
  • PCIPL
  • Privi Speciality Chemicals Limited
  • Robertet SA
  • Sivaroma Naturals
  • Symrise AG
  • T. Hasegawa Co., Ltd.
  • Takasago International Corporation